Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
2
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
2
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
life sciences
2
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
ad-comm
affimed
akcea therapeutics
akouos
allergan
allogene therapeutics
What
bio
ipo
roundup
years
2
×
acquisitions
allogene
announced
cancer
ceo
collabs
covid
crispr
daniel
deal
diversity
gilead
gilead’s
help
hot
immunotherapy
introduce
investors
juno
medicines
million
month
nearly
new
o’day
plans
remains
sciences
shares
snapped
therapeutics
ticket
transformative
utero
Language
unset
Current search:
biogen
×
" seattle top stories "
×
years
×
" life sciences "
×
crispr
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More